Fingolimod leads to early clinical and MRI benefits in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Chin, P.
von Rosenstiel, P.
Haering, D.
Francis, G.
Kappos, L.
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S70 / S71
页数：2
相关论文
共 50 条
  • [21] Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
    Ghadiri, Fereshteh
    Mirmosayyeb, Omid
    Sahraian, Mohammad Ali
    Moghadasi, Abdorreza Naser
    Ghajarzadeh, Mahsa
    CURRENT JOURNAL OF NEUROLOGY, 2023, 22 (02): : 110 - 114
  • [22] Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis
    Kalincik, Tomas
    Horakova, Dana
    Spelman, Tim
    Jokubaitis, Vilija
    Trojano, Maria
    Lugaresi, Alessandra
    Izquierdo, Guillermo
    Rozsa, Csilla
    Grammond, Pierre
    Alroughani, Raed
    Duquette, Pierre
    Girard, Marc
    Pucci, Eugenio
    Lechner-Scott, Jeannette
    Slee, Mark
    Fernandez-Bolanos, Ricardo
    Grand'Maison, Francois
    Hupperts, Raymond
    Verheul, Freek
    Hodgkinson, Suzanne
    Oreja-Guevara, Celia
    Spitaleri, Daniele
    Barnett, Michael
    Terzi, Murat
    Bergamaschi, Roberto
    McCombe, Pamela
    Sanchez-Menoyo, Jose
    Simo, Magdolna
    Csepany, Tunde
    Rum, Gabor
    Boz, Cavit
    Havrdova, Eva
    Butzkueven, Helmut
    ANNALS OF NEUROLOGY, 2015, 77 (03) : 425 - 435
  • [23] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Cavit Boz
    Serkan Ozakbas
    Murat Terzi
    Rana Karabudak
    Serhan Sevim
    Recai Turkoglu
    Aysun Soysal
    Belgin Petek Balcı
    Hüsnü Efendi
    Ömer Faruk Turan
    Nur Yüceyar
    Mehmet Fatih Yetkin
    Serap Zengin Karahan
    Meltem Demirkıran
    Sibel Guler
    Kadriye Agan
    Nefati Kıylıoğlu
    Cavid Baba
    Asli Tuncer
    Mesrure Köseoğlu
    Neurological Sciences, 2023, 44 : 2121 - 2129
  • [24] Drug holiday therapy of fingolimod in Japanese relapsing-remitting multiple sclerosis
    Ohtani, R.
    Masahiro, M.
    Akiyuki, U.
    Tomohiko, U.
    Hiroki, M.
    Satoshi, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 792 - 793
  • [25] Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
    Yavari, Fatemeh
    Oliazadeh, Pardis
    Radfar, Meisam
    Foroughipour, Mohsen
    Nikkhah, Karim
    Bakavoli, Alireza Heidari
    Saeidi, Morteza
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (02) : 233 - 242
  • [26] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Boz, Cavit
    Ozakbas, Serkan
    Terzi, Murat
    Karabudak, Rana
    Sevim, Serhan
    Turkoglu, Recai
    Soysal, Aysun
    Balci, Belgin Petek
    Efendi, Husnu
    Turan, Omer Faruk
    Yuceyar, Nur
    Yetkin, Mehmet Fatih
    Karahan, Serap Zengin
    Demirkiran, Meltem
    Guler, Sibel
    Agan, Kadriye
    Kiylioglu, Nefati
    Baba, Cavid
    Tuncer, Asli
    Koseoglu, Mesrure
    NEUROLOGICAL SCIENCES, 2023, 44 (06) : 2121 - 2129
  • [27] Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Haenni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Oezguer
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 941 - 949
  • [28] Fingolimod for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia
    Algahtani, Hussein
    Shirah, Bader
    Al Malik, Yaser
    Meftah, Ibraheem
    CLINICAL NEUROPHARMACOLOGY, 2020, 43 (02) : 35 - 38
  • [29] Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis
    Boz, Cavit
    Terzi, Murat
    Ozer, Bilge
    Turkoglu, Recai
    Karabudak, Rana
    Efendi, Husnu
    Soysal, Aysun
    Sevim, Serhan
    Altintas, Ayse
    Kurne, Asli
    Akcali, Aylin
    Akman, Gulsen
    Yuceyar, Nur
    Balci, Belgin Petek
    Ekmekci, Ozgul
    Karahan, Serap Zengin
    Demirkiran, Meltem
    Altunrende, Burcu
    Turan, Omer Faruk
    GozubatikCelik, Gokcen
    Kale, Nilufer
    Koseoglu, Mesrure
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 36
  • [30] The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis
    Kotov, S. V.
    Fedorova, S. I.
    Yakushina, T. I.
    Lizhdvoy, V. Yu
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (02) : 74 - 78
12345